Simplex Trading’s Standard BioTools LAB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.68K | Buy |
+2,915
| New | +$3.53K | ﹤0.01% | 8252 |
|
|
2025
Q2 | – | Sell |
-5,574
| Closed | -$6.18K | – | 9242 |
|
|
2025
Q1 | $6K | Sell |
5,574
-2,007
| -26% | -$2.82K | ﹤0.01% | 7456 |
|
|
2024
Q4 | $13K | Sell |
7,581
-4,327
| -36% | -$8.06K | ﹤0.01% | 7004 |
|
|
2024
Q3 | $22K | Buy |
11,908
+7,889
| +196% | +$15.4K | ﹤0.01% | 6606 |
|
|
2024
Q2 | $7K | Buy |
+4,019
| New | +$9.82K | ﹤0.01% | 7680 |
|
|
2024
Q1 | – | Sell |
-438
| Closed | -$1.06K | – | 9378 |
|
|
2023
Q4 | $0 | Sell |
438
-960
| -69% | -$2.05K | ﹤0.01% | 9363 |
|
|
2023
Q3 | $4K | Sell |
1,398
-7,167
| -84% | -$18.7K | ﹤0.01% | 7780 |
|
|
2023
Q2 | $16K | Sell |
8,565
-9,578
| -53% | -$18.9K | ﹤0.01% | 6976 |
|
|
2023
Q1 | $35K | Buy |
18,143
+14,139
| +353% | +$27.9K | ﹤0.01% | 6329 |
|
|
2022
Q4 | $4K | Sell |
4,004
-6,098
| -60% | -$7.51K | ﹤0.01% | 8218 |
|
|
2022
Q3 | $11K | Buy |
+10,102
| New | +$15.3K | ﹤0.01% | 8145 |
|
|
2022
Q2 | – | Sell |
-33,829
| Closed | -$83.7K | – | 10557 |
|
|
2022
Q1 | $121K | Buy |
33,829
+26,413
| +356% | +$91.2K | ﹤0.01% | 5877 |
|
|
2021
Q4 | $29K | Sell |
7,416
-19,017
| -72% | -$89K | ﹤0.01% | 7941 |
|
|
2021
Q3 | $161K | Sell |
26,433
-1,400
| -5% | -$9.21K | ﹤0.01% | 5944 |
|
|
2021
Q2 | $171K | Sell |
27,833
-6,304
| -18% | -$33.7K | ﹤0.01% | 5938 |
|
|
2021
Q1 | $154K | Buy |
+34,137
| New | +$188K | ﹤0.01% | 5141 |
|
|
2020
Q4 | – | Sell |
-29,761
| Closed | -$196K | – | 8732 |
|
|
2020
Q3 | $221K | Buy |
+29,761
| New | +$205K | ﹤0.01% | 3976 |
|
|
2020
Q2 | – | Sell |
-1,542
| Closed | -$5.37K | – | 7983 |
|
|
2020
Q1 | $3K | Sell |
1,542
-4,352
| -74% | -$14.3K | ﹤0.01% | 7066 |
|
|
2019
Q4 | $20K | Sell |
5,894
-1,566
| -21% | -$5.51K | ﹤0.01% | 5951 |
|
|
2019
Q3 | $34K | Buy |
7,460
+4,337
| +139% | +$34.2K | ﹤0.01% | 5375 |
|
|
2019
Q2 | $38K | Sell |
3,123
-374
| -11% | -$4.76K | ﹤0.01% | 5087 |
|
|
2019
Q1 | $46K | Buy |
+3,497
| New | +$36.9K | ﹤0.01% | 5070 |
|
|
2018
Q4 | – | Sell |
-17,096
| Closed | -$133K | – | 7426 |
|
|
2018
Q3 | $128K | Buy |
+17,096
| New | +$122K | ﹤0.01% | 4163 |
|
|
2018
Q2 | – | Sell |
-9,382
| Closed | -$53.5K | – | 7641 |
|
|
2018
Q1 | $54K | Buy |
+9,382
| New | +$61.6K | ﹤0.01% | 2358 |
|
|
2017
Q4 | – | Sell |
-5,561
| Closed | -$30.4K | – | 6333 |
|
|
2017
Q3 | $28K | Sell |
5,561
-842
| -13% | -$3.54K | ﹤0.01% | 2840 |
|
|
2017
Q2 | $25K | Buy |
6,403
+4,530
| +242% | +$21.5K | ﹤0.01% | 3087 |
|
|
2017
Q1 | $10K | Buy |
1,873
+1,454
| +347% | +$9.21K | ﹤0.01% | 3974 |
|
|
2016
Q4 | $3K | Buy |
+419
| New | +$2.63K | ﹤0.01% | 4750 |
|
|
2016
Q1 | – | Sell |
-1,781
| Closed | -$12.8K | – | 5918 |
|
|
2015
Q4 | $19K | Sell |
1,781
-3,025
| -63% | -$29.7K | ﹤0.01% | 2742 |
|
|
2015
Q3 | $38K | Buy |
4,806
+3,772
| +365% | +$59.4K | ﹤0.01% | 2210 |
|
|
2015
Q2 | $25K | Buy |
+1,034
| New | +$32.6K | ﹤0.01% | 2264 |
|
|
2015
Q1 | – | Sell |
-447
| Closed | -$17.7K | – | 5267 |
|
|
2014
Q4 | $15K | Buy |
+447
| New | +$12.7K | ﹤0.01% | 2279 |
|
Other funds holding LAB
CC
MCO
LFCM
VCM
HBWM
Simplex Trading's LAB Position: Q1 2026 in Review
Simplex Trading opened a new position in Standard BioTools (LAB) in Q1 2026: 2,915 shares worth $2.68K. The stake represents ﹤0.01% of the portfolio and ranks #8252 among its holdings. This is a return to the name: Simplex Trading previously reported a position in LAB as recently as Q1 2025.
Simplex Trading first reported a position in LAB in Q4 2014 and has held it in 32 quarters since. The position peaked at $221K in Q3 2020. 155 funds tracked by Wall St. Rank hold LAB as of Q1 2026.
- Simplex Trading held 2,915 shares of Standard BioTools worth $2.68K as of Q1 2026.
- Standard BioTools was a new Simplex Trading position in Q1 2026.
- Standard BioTools made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #8252 holding.
- Simplex Trading first reported a position in Standard BioTools in Q4 2014 and has held it in 32 quarters since.
- Simplex Trading's Standard BioTools position peaked at $221K in Q3 2020.
- 155 funds tracked by Wall St. Rank held Standard BioTools as of Q1 2026.
Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.